1. Home
  2. VSTM vs STCN Comparison

VSTM vs STCN Comparison

Compare VSTM & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • STCN
  • Stock Information
  • Founded
  • VSTM 2010
  • STCN 1986
  • Country
  • VSTM United States
  • STCN United States
  • Employees
  • VSTM N/A
  • STCN N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • STCN Advertising
  • Sector
  • VSTM Health Care
  • STCN Consumer Discretionary
  • Exchange
  • VSTM Nasdaq
  • STCN Nasdaq
  • Market Cap
  • VSTM 132.0M
  • STCN 63.4M
  • IPO Year
  • VSTM 2012
  • STCN 1994
  • Fundamental
  • Price
  • VSTM $3.88
  • STCN $10.40
  • Analyst Decision
  • VSTM Strong Buy
  • STCN
  • Analyst Count
  • VSTM 8
  • STCN 0
  • Target Price
  • VSTM $14.57
  • STCN N/A
  • AVG Volume (30 Days)
  • VSTM 1.1M
  • STCN 11.9K
  • Earning Date
  • VSTM 11-06-2024
  • STCN 12-12-2024
  • Dividend Yield
  • VSTM N/A
  • STCN N/A
  • EPS Growth
  • VSTM N/A
  • STCN 203.29
  • EPS
  • VSTM N/A
  • STCN 3.17
  • Revenue
  • VSTM $10,000,000.00
  • STCN $169,044,000.00
  • Revenue This Year
  • VSTM N/A
  • STCN N/A
  • Revenue Next Year
  • VSTM $125.69
  • STCN N/A
  • P/E Ratio
  • VSTM N/A
  • STCN $3.19
  • Revenue Growth
  • VSTM N/A
  • STCN N/A
  • 52 Week Low
  • VSTM $2.10
  • STCN $7.36
  • 52 Week High
  • VSTM $14.22
  • STCN $13.00
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 63.77
  • STCN 57.19
  • Support Level
  • VSTM $3.11
  • STCN $9.90
  • Resistance Level
  • VSTM $3.76
  • STCN $10.29
  • Average True Range (ATR)
  • VSTM 0.33
  • STCN 0.39
  • MACD
  • VSTM 0.04
  • STCN 0.11
  • Stochastic Oscillator
  • VSTM 94.26
  • STCN 100.00

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

Share on Social Networks: